• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

prostate cancer

prostate cancer PSA test
MedTech

Alpenglow teams up with Virdx to boost prostate cancer diagnosis

Alpenglow has penned a new pact with Virdx to create the next generation of AI-powered diagnostic tools for prostate cancer.
Ben Adams Oct 8, 2025 9:20am
GE Healthcare Building

Lantheus taps GE HealthCare to sell its PSMA PET tracer in Japan

Sep 24, 2025 11:30am
A series of dice with a bag on them illustrating cost cuts

Oric lays off 20% of workforce in focus on clinical-stage drugs

Aug 13, 2025 6:20am
Paint brushes sitting on a colorful canvas

Radiopharma biotech Artbio paints path to clinic with $132M

Jul 29, 2025 7:30am
MA strategy deal block push come together form

Research non-profit acquires embattled Essa in Xoma-backed deal

Jul 14, 2025 9:30am
Micrograph showing the most common prostate cancer

Nuclidium raises $99M for copper-based radiopharma pipeline

Jul 10, 2025 5:04am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings